The expansion – expected to be completed in 2021 – will see the addition of a new isolator enclosed fill line.
Groninger & Co. will install the FlexPro 50 filler with isolator technology and an integrated Christ lyophilizer at the company's facility in Baltimore. The line will have the capability to fill vials, syringes, and cartridges.
Additionally, Emergent BioSolutions will be adding a second autoclave to increase its sterilization capacity and provide manufacturing redundancy.
The addition also will provide new cold storage space to support 2-8⁰c and -20⁰c requirements, new stability chambers, new media fill incubators, and additional warehousing and office space, according to the company.
An additional 60 new jobs are expected to be created in the next three years, according to the contract development and manufacturing organization (CDMO).
BJ Hull, vice president, general manager and site head at the Camden facility, said in a press release: “This $50 million investment further demonstrates our commitment to meeting and exceeding the expectations of our customers as well as to stimulating economic growth and creating jobs in Baltimore.”